Concepedia

Marcelo V. Negrão

MV

Statistics

Publications

63

Citations

5.6K

H-Index

34

Active since

2010

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

NYU Langone Health

Massachusetts General Hospital

Dana-Farber Cancer Institute

Instituto do Câncer do Estado de São Paulo

Marcelo V. Negrão is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

2010–2025

63

Publications

63

Adagrasib in Non–Small-Cell Lung Cancer Harboring a <i> KRAS <sup>G12C</sup> </i> Mutation

Pasi A. Jänne, Gregory J. Riely, Shirish M. Gadgeel et al. · New England Journal of Medicine · 2022 · 984 citations · Full text

, , +15

Landscape of EGFR-Dependent and -Independent Resistance Mechanisms to Osimertinib and Continuation Therapy Beyond Progression in <i>EGFR</i> -Mutant NSCLC

Xiuning Le, Sonam Puri, Marcelo V. Negrão et al. · Clinical Cancer Research · 2018 · 386 citations

, , +17

Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer

Marcelo V. Negrão, Ferdinandos Skoulidis, Meagan Montesion et al. · Journal for ImmunoTherapy of Cancer · 2021 · 292 citations · Full text

, , +17

Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DM1 Activity

Jacqulyne Robichaux, Yasir Y. Elamin, R. S. K. Vijayan et al. · Cancer Cell · 2019 · 241 citations · Full text

, , +14

Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial

Tina Cascone, Cheuk Hong Leung, Annikka Weissferdt et al. · Nature Medicine · 2023 · 206 citations · Full text

, , +17

1–5 of 63